Morning Star - research on CBA trading site.
It is also developing other products to reduce the risk of a single product portfolio. These include Thermospheres - magnetic microspheres for liver cancer - that generate heat via induction, and a worldwide licence agreement with the Peter MacCallum Cancer Centre in Melbourne for their radioprotector technology. These latter compounds protect healthy tissue from the harmful effects of radiation.
- Forums
- ASX - By Stock
- SRX
- Ann: Clinical Study Result
Ann: Clinical Study Result , page-18
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)